146 related articles for article (PubMed ID: 1950942)
1. Serum IgD behaviour in HIV-1 infected patients.
Raiteri R; Albonico M; Deiana R; Marietti G; Sinicco A
Allergol Immunopathol (Madr); 1991; 19(1):6-10. PubMed ID: 1950942
[TBL] [Abstract][Full Text] [Related]
2. Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users.
Rezza G; Titti F; Pezzotti P; Sernicola L; Lo Caputo S; Angarano G; Lazzarin A; Sinicco A; Rossi GB; Verani P
J Biol Regul Homeost Agents; 1992; 6(1):15-20. PubMed ID: 1359736
[TBL] [Abstract][Full Text] [Related]
3. [Immunologic study in HIV-positive patients. Hypergammaglobulinemia in HIV infection].
Skokanová V; Kamínková J; Vacek Z; Stanková M
Cas Lek Cesk; 1993 Jun; 132(12):369-72. PubMed ID: 8343945
[TBL] [Abstract][Full Text] [Related]
4. Behaviour of different clinical, immunological and serological parameters observed in a group of HIV positive patients during a 12 month treatment period with zidovudine.
Crocchiolo PR; Lizioli A; Arcidiacono I; Cantaluppi P; Filippi C; Sobatti D; Bedarida G; D'Agostino F; Cambie G; Nardella ML
Boll Ist Sieroter Milan; 1990 Jun; 69(2):423-30. PubMed ID: 1983798
[TBL] [Abstract][Full Text] [Related]
5. Comparative study on some systemic humoral and cellular immune markers in only HIV or HIV and hepatitis B infected children.
Voiculescu C; Bălăşoiu M; Turculeanu A; Filipaş L; Voiculescu M; Georgescu D
Rom J Virol; 1993; 44(1-2):97-111. PubMed ID: 9702255
[TBL] [Abstract][Full Text] [Related]
6. [Serum neopterin and beta2-microglobulin concentration as "prognostic markers" of AIDS].
Halota W; Jaruga B; Pawłowska M
Pol Merkur Lekarski; 2002 Aug; 13(74):126-8. PubMed ID: 12420343
[TBL] [Abstract][Full Text] [Related]
7. [Dynamics of the antibody response and p24 antigenemia in HIV-1 infected individuals in Czechoslovakia].
Kopecká D; Brůcková M; Stanková M; Syrůcek L; Vojtĕchovský K; Petkov V
Cesk Epidemiol Mikrobiol Imunol; 1990 Mar; 39(2):65-73. PubMed ID: 2142624
[TBL] [Abstract][Full Text] [Related]
8. IgD production and other lymphocyte functions in HIV infection: immaturity and activation of B cells at different clinical stages.
Rogers LA; Forster SM; Pinching AJ
Clin Exp Immunol; 1989 Jan; 75(1):7-11. PubMed ID: 2784730
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin profile in HIV-1 infected children in Dar es Salaam.
Lyamuya EF; Matee MI; Kasubi M; Scheutz F
East Afr Med J; 1999 Jul; 76(7):370-5. PubMed ID: 10520363
[TBL] [Abstract][Full Text] [Related]
10. Beta 2-microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women.
Jackson JB; Kataaha P; Hom DL; Mmiro F; Guay L; Ndugwa C; Marum L; Piwowar E; Brewer K; Toedter G
AIDS; 1993 Nov; 7(11):1475-9. PubMed ID: 8280414
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
[TBL] [Abstract][Full Text] [Related]
12. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
[TBL] [Abstract][Full Text] [Related]
13. Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline.
Lange JM; de Wolf F; Krone WJ; Danner SA; Coutinho RA; Goudsmit J
AIDS; 1987 Sep; 1(3):155-9. PubMed ID: 3126756
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic significance of antibodies to HIV nuclear proteins in patients with the lymphadenopathy syndrome].
Schulte C; Meurer M; Fröschl M
Hautarzt; 1988 Jan; 39(1):45-8. PubMed ID: 3162727
[TBL] [Abstract][Full Text] [Related]
15. [Subjects infected with human immunodeficiency virus: serological markers of prognostic value].
Hurtado C; Velasco M; Sepúlveda C
Rev Med Chil; 1989 Mar; 117(3):251-7. PubMed ID: 2488516
[TBL] [Abstract][Full Text] [Related]
16. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
17. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
[TBL] [Abstract][Full Text] [Related]
18. [Immunoglobulin A and human immunodeficiency virus type 1 infection in parenteral drug abuse addicts].
Muga R; Tor J; Solsona L; Villanueva C; Pol M; Jacas C; Sabriá M; Rey-Joly C; Foz M
Med Clin (Barc); 1991 Mar; 96(10):361-3. PubMed ID: 2046411
[TBL] [Abstract][Full Text] [Related]
19. Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection.
Ljunggren K; Karlson A; Fenyö EM; Jondal M
Clin Exp Immunol; 1989 Feb; 75(2):184-9. PubMed ID: 2649286
[TBL] [Abstract][Full Text] [Related]
20. Serum beta 2-microglobulin and human immunodeficiency virus infection.
Lacey JN; Forbes MA; Waugh MA; Cooper EH; Hambling MH
AIDS; 1987 Jul; 1(2):123-7. PubMed ID: 3130078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
